Showing results (171-180 of 241) with videos related to
Sort By:
Pageof 25
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.American Journal of Hematology|August 18, 2017
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITYStuart L Goldberg, Jorge E Cortes, Carlo Gambacorti-Passerini, et al.Blood|June 18, 2010
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient miceHelena Agerstam, Marcus Järås, Anna Andersson, et al.Haematologica|December 30, 2017
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targetingNiklas Landberg, Sofia von Palffy, Maria Askmyr, et al.Blood|October 13, 2011
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemiaPekka Jaako, Johan Flygare, Karin Olsson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008Magnus Björkholm, Lotta Ohm, Sandra Eloranta, et al.European Journal of Haematology|July 19, 2016
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML registerStina Söderlund, Torsten Dahlén, Fredrik Sandin, et al.British Journal of Haematology|March 31, 2015
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor eraNiklas Gunnarsson, Leif Stenke, Martin Höglund, et al.Blood|August 4, 2012
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.Pageof 25